#FTSE #Nasdaq Due to a little bout of leukaemia, I’m probably more interested in Hemogenyx than most people should have any right to. Most folk, wandering down a cancer path, start to become extremely frustrated at all the nonsense “cures” constantly promised in clickbait stories. Some promise cures in a vague tomorrow, some promise cures with miracle herbs, spices, or berries but unfortunately, not a single person is ever cured by a “promise”. Eventually, by the simple expedient of not buying newspapers, folk insulate themselves from constant disappointment.
One such “promise” sticks in mind, the promise of Stem Cell treatment. The newspaper article made it all sound very simple. A compatible family member would be sat in one chair and plumbed into a special machine. The person suffering from a cancer would sit alongside and also plumbed in. After a few hours, Stem Cells would be transferred from the healthy person to the ill one and voila, within just a few weeks a blood cancer would be eradicated. The media made it read like a simple process, one which would be available to everyone. But the reality was it was just in testing and wonderful early results didn’t stand the test of time. Companies involved in the field had a lot more work to do but for months, nurses and consultants in cancer units were being bombarded with questions by patients who felt ignored by not being offered the miracle treatment.
Before sounding terribly dramatic, my own version of leukaemia isn’t fatal, requiring regular (daily in my case) tedious chemotherapy. I do keep a weather eye open, glancing at the inevitable medical journals which grace the waiting room of the vampire unit which specialises in blood disorders but the mantra, “don’t hold your breath” remains the best advice possible. However, a recent email jelled with an article I’d read about Hemogenyx Pharmaceuticals, a company we previously reviewed a few years ago, one which is active in my own field, and also a share price which we were not terribly enthusiastic about.
As expected, their share price crumbled but didn’t actually reach our ‘worst case’ ultimate bottom of 0.75p, instead falling to an all time low of just 1p and doing very little useful in the period since. This failure to attain an ultimate bottom actually justifies some hope, usually indicating hidden strength. The immediate situation certainly gives an excuse for some optimism, allowing us to create a scenario where above just 3.5p should next trigger share price recovery to an initial 4.8p with our secondary, if beaten, a cheerful looking 6.75p. Visually, there’s an almost certain expectation of some hesitation at the 6.75p level but in this instance, beware if the market opts to gap the share upward by around 0.7p, if the company opt to provide good news.
Such an event shall be regarded as significant, moving the price into a region where upward travel of some strength becomes expected. Despite an obvious personal bias, we suspect this shall prove worthy of watching.
FUTURES
| Time Issued | Market | Price At Issue | Short Entry | Fast Exit | Slow Exit | Stop | Long Entry | Fast Exit | Slow Exit | Stop | Prior |
| 9:57:58PM | BRENT | 7926.9 | ‘cess | ||||||||
| 10:00:11PM | GOLD | 2028.97 | ‘cess | ||||||||
| 10:04:15PM | FTSE | 7506.1 | 7457 | 7434 | 7403 | 7507 | 7529 | 7562 | 7615 | 7483 | |
| 10:15:50PM | STOX50 | 4483.3 | Shambles | ||||||||
| 10:18:27PM | GERMANY | 16678.5 | ‘cess | ||||||||
| 10:21:36PM | US500 | 4871.3 | |||||||||
| 10:24:01PM | DOW | 37924.5 | ‘cess | ||||||||
| 10:26:40PM | NASDAQ | 17428 | 17284 | 17258 | 17198 | 17370 | 17434 | 17452 | 17508 | 17374 | Shambles |
| 10:30:09PM | JAPAN | 36511 | ‘cess |
23/01/2024 FTSE Closed at 7486 points. Change of -0.01%. Total value traded through LSE was: £ 5,145,475,949 a change of 1.4%
22/01/2024 FTSE Closed at 7487 points. Change of 0.35%. Total value traded through LSE was: £ 5,074,323,347 a change of -15.67%
19/01/2024 FTSE Closed at 7461 points. Change of 0.03%. Total value traded through LSE was: £ 6,017,076,844 a change of 5.37%
18/01/2024 FTSE Closed at 7459 points. Change of 0.17%. Total value traded through LSE was: £ 5,710,434,313 a change of 4.63%
17/01/2024 FTSE Closed at 7446 points. Change of -1.48%. Total value traded through LSE was: £ 5,457,663,350 a change of -3.81%
16/01/2024 FTSE Closed at 7558 points. Change of -0.47%. Total value traded through LSE was: £ 5,673,801,232 a change of 52.3%
15/01/2024 FTSE Closed at 7594 points. Change of -0.39%. Total value traded through LSE was: £ 3,725,366,941 a change of -35.31% 
SUCCESS above means both FAST & SLOW targets were met. ‘CESS means just the FAST target met and probably the next time it is exceeded, movement to the SLOW target shall commence.
Our commentary is in two sections. Immediately below are today’s updated comments. If our commentary remains valid, the share can be found in the bottom section which has a RED heading. Hopefully, this will mean you no longer need to flip back through previous reports. HYPERLINKS DISABLED IN THIS VERSION
Please remember, all prices are mid-price (halfway between the Buy and Sell). When we refer to a price CLOSING above a specific level, we are viewing the point where we can regard a trend as changing. Otherwise, we are simply speculating on near term trading targets. Our website is www.trendsandtargets.com.
UPDATE. We often give an initial and a secondary price. If the initial is exceeded, we still expect it to fall back but the next time the initial is bettered, the price should continue to the secondary. The converse it true with price drops.
We can be contacted at info@trendsandtargets.com. Spam filters set to maximum so only legit emails get through…
Section One – Outlook Updated Today. Click here for Section Two – Outlook Remains Valid shares
Click Epic to jump to share: LSE:AV. Aviva** **LSE:DGE Diageo** **LSE:FOXT Foxtons** **LSE:LLOY Lloyds Grp.** **
********
Updated charts published on : Aviva, Diageo, Foxtons, Lloyds Grp.,
LSE:AV. Aviva Close Mid-Price: 433.2 Percentage Change: -1.39% Day High: 441.9 Day Low: 434.3
All Aviva needs are mid-price trades ABOVE 441.9 to improve acceleration ……..
</p
View Previous Aviva & Big Picture ***
LSE:DGE Diageo Close Mid-Price: 2685.5 Percentage Change: -0.56% Day High: 2711 Day Low: 2676
In the event Diageo experiences weakness below 2676 it calculates with a ……..
</p
View Previous Diageo & Big Picture ***
LSE:FOXT Foxtons. Close Mid-Price: 54.1 Percentage Change: + 1.50% Day High: 56 Day Low: 53.6
Target met. Continued trades against FOXT with a mid-price ABOVE 56 shoul ……..
</p
View Previous Foxtons & Big Picture ***
LSE:LLOY Lloyds Grp. Close Mid-Price: 43.06 Percentage Change: -0.83% Day High: 43.85 Day Low: 43.09
The share from hell continues to confirm its residence in somewhere like M ……..
</p
View Previous Lloyds Grp. & Big Picture ***